Evidence map›Paper›PMID 34077290›Full record

SynthesisMicrobial drug resistance (Larchmont, N.Y.)2021

The Spectrum of Antibiotic Prescribing During COVID-19 Pandemic: A Systematic Literature Review.

Sara H Al-Hadidi, Hashim Alhussain, Hamad Abdel Hadi, Alreem Johar, Hadi M Yassine, Asmaa A Al Thani, Nahla O Eltai

Abstract readSystematic Review
In one paragraph

Synthesis in Microbial drug resistance (Larchmont, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Perspective on the Integration of Diagnostic Algorithms for Fever Management.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sara H Al-HadidiBiomedical Research Center, Qatar University, Doha, Qatar.
Hashim AlhussainBiomedical Research Center, Qatar University, Doha, Qatar.
Hamad Abdel HadiInfectious Disease Division, Communicable Diseases Centre, Hamad Medical Corporation, Doha, Qatar.
Alreem JoharBarzan Holdings, Doha, Qatar.
Hadi M YassineBiomedical Research Center, Qatar University, Doha, Qatar.
Asmaa A Al ThaniBiomedical Research Center, Qatar University, Doha, Qatar.
Nahla O EltaiBiomedical Research Center, Qatar University, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19 Drug TreatmentAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsChildChild, PreschoolComorbidityDrug UtilizationFemaleHumansInfantInfant, NewbornMaleMiddle AgedAnti-Bacterial AgentsAMRantibioticsantimicrobial stewardshipCOVID-19resistance

Identifiers

PMID34077290
PMCPMC8713256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.